Intellectual Property India Publishes Patent Application for 'Anti-Alpha V Beta 8 Integrin Antibodies And Methods Of Use' Filed by Genentech, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099358 A) filed by Genentech, Inc., San Francisco, on Oct. 14, for 'anti-alpha v beta 8 integrin antibodies and methods of use.'

Inventor(s) include Lin, Weiyu; Loyet, Kelly Michele; Masureel, Matthieu; Thai, Minh; Turley, Shannon Jennifer; Tyagi, Tulika; Wu, Yan; Zhang, Jianhuan; Castiglioni, Alessandra; and Chiu, Cecilia Pui Chi.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are anti-a?8 antibodies or antigen-binding portions thereof and methods of making and using the same. Further provided are methods of treating cancer with an anti-a?8 and a PD-1 axis antagonist."

The patent application was internationally filed on Mar. 29, 2024, under International application No.PCT/US2024/022187.

Disclaimer: Curated by HT Syndication.